DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rose 3.38% to $439.37 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 3.26% to 5,844.19 and the Dow Jones Industrial Average rising 2.81% to 42,410.10.
The stock's rise snapped a five-day losing streak.
Vertex Pharmaceuticals Inc. closed 15.49% below its 52-week high of $519.88, which the company reached on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ rose 2.96% to $190.07, Krystal Biotech Inc. (KRYS) rose 5.48% to $139.43, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 5.56% to $11.59.
Trading volume (2.1 M) eclipsed its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 12, 2025 16:36 ET (20:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.